Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 70 articles:
HTML format
Text format



Single Articles


    July 2017
  1. NIEMANN B, Rohrbach S, Miller MR, Newby DE, et al
    Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series.
    J Am Coll Cardiol. 2017;70:230-251.
    PubMed     Text format     Abstract available


    June 2017
  2. BHATT DL, Grosser T, Dong JF, Logan D, et al
    Reply: Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
    J Am Coll Cardiol. 2017;69:2879.
    PubMed     Text format    


  3. CERIT L, Duygu H
    Collapse of the Aspirin Empire: Is it Diabetic Gastroparesis or Cardioprotective Paresis?
    J Am Coll Cardiol. 2017;69:2878-2879.
    PubMed     Text format    


  4. JANUZZI JL JR, Butler J, Jarolim P, Sattar N, et al
    Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes.
    J Am Coll Cardiol. 2017 Jun 9. pii: S0735-1097(17)37754.
    PubMed     Text format     Abstract available


    May 2017
  5. SATTAR N, Petrie MC, Zinman B, Januzzi JL Jr, et al
    Novel Diabetes Drugs and the Cardiovascular Specialist.
    J Am Coll Cardiol. 2017;69:2646-2656.
    PubMed     Text format     Abstract available


  6. STONE PH
    Ranolazine in Diabetics With Stable Ischemic Heart Disease: Greatest Efficacy Related to Greatest Metabolic Stress.
    J Am Coll Cardiol. 2017;69:2314-2316.
    PubMed     Text format    


  7. FANAROFF AC, James SK, Weisz G, Prather K, et al
    Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    J Am Coll Cardiol. 2017;69:2304-2313.
    PubMed     Text format     Abstract available


    January 2017
  8. PICCINI JP, Granger CB
    Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?
    J Am Coll Cardiol. 2017;69:420-422.
    PubMed     Text format    


  9. PATTI G, Lucerna M, Cavallari I, Ricottini E, et al
    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
    J Am Coll Cardiol. 2017;69:409-419.
    PubMed     Text format     Abstract available


  10. SERRUYS PW, Farooq V
    Cherry-Picking Historical Data to Legitimize Contemporary Practice: Should Diabetic Status Influence Decision-Making in Complex CAD?
    J Am Coll Cardiol. 2017;69:404-408.
    PubMed     Text format    


  11. ISHIKAWA K
    The Transgenic Diabetic Pig Heart: A "Sweet Heart" for Translational Cardiovascular Research.
    J Am Coll Cardiol. 2017;69:144-146.
    PubMed     Text format    


  12. HINKEL R, Hoewe A, Renner S, Ng J, et al
    Diabetes Mellitus-Induced Microvascular Destabilization in the Myocardium.
    J Am Coll Cardiol. 2017;69:131-143.
    PubMed     Text format     Abstract available


  13. VAN DIEPEN S, Fuster V, Verma S, Hamza TH, et al
    Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights.
    J Am Coll Cardiol. 2017;69:119-127.
    PubMed     Text format     Abstract available


  14. BHATT DL, Grosser T, Dong JF, Logan D, et al
    Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37323.
    PubMed     Text format     Abstract available


  15. PATRONO C, Rocca B
    Type 2 Diabetes, Obesity, and Aspirin Responsiveness.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37320.
    PubMed     Text format    


    December 2016
  16. DE GONZALO-CALVO D, Kenneweg F, Bang C, Toro R, et al
    Circulating Long Noncoding RNAs in Personalized Medicine: Response to Pioglitazone Therapy in Type 2 Diabetes.
    J Am Coll Cardiol. 2016;68:2914-2916.
    PubMed     Text format    


  17. LEVELT E, Neubauer S
    Reply: Ectopic Fat Deposition and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68:2595.
    PubMed     Text format    


  18. GABORIT B, Dutour A
    Ectopic Fat Deposition and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68:2594-2595.
    PubMed     Text format    


    November 2016
  19. CHO MS, Do U, Lee K, Hong JA, et al
    TCT-242 Temporal Changes in Outcomes after Stent or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease by Diabetes Status.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  20. HAMZA M, Elgendy I
    TCT-139 A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  21. GARCIA E, Hong S, Cho SA, Cho JY, et al
    TCT-108 Comparison of Ticagrelor versus Prasugrel on Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting: Prospective,
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  22. KOVARNIK T, Chen Z, Wahle A, Fukumoto Y, et al
    TCT-96 Progression of coronary atherosclerosis despite lipid-lowering therapy in diabetic patients compared to non-dibetic ones. Study with 3D intravascular ultrasound and virtual histology.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  23. KEDHI E, Kennedy M, Maehara A, Lansky A, et al
    TCT-94 Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  24. JANAS A, Buszman P, Milewski K, Krol M, et al
    TCT-803 Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  25. MINA G, Gill P, Soliman D, Reddy P, et al
    TCT-728 Impact Of Diabetes Mellitus On Outcomes Of Transcatheter Aortic Valve Replacement: A Meta-analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  26. GOMEZ MENCHERO A, Balaguer J, Lopez Otero D, Piris RM, et al
    TCT-72 Short and medium-term clinical outcome of amphilimus polymer-free drug-eluting stent in diabetic patients: An all-comers multicenter spanish registry. (Control-8 registry).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  27. KALKMAN D, Woudstra P, Den Heijer P, Alexander Menown IB, et al
    TCT-68 One Year Clinical Outcomes in Patients with Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-Comers R
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  28. LINDMAN B, Abramowitz Y, Pibarot P, Quader N, et al
    TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  29. FAGGIONI M, Farhan S, Baber U, Giustino G, et al
    TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  30. CHANDRASEKHAR J, Redfors B, Genereux P, Kirtane A, et al
    TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  31. CAVALCANTE R, Sotomi Y, Suwannasom P, Lee CW, et al
    TCT-67 Impact of the SYNTAX score in patients with diabetes and left-main and/or multivessel coronary disease: a pooled analysis of individual patient level data from the SYNTAX, PRECOMBAT and BEST trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  32. ABRAMOWITZ Y, Lindman B, Chakravarty T, Jilaihawi H, et al
    TCT-661 The Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights from the PARTNER II SAPIEN 3 Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  33. FURER A, Ben-Yehuda O, Redfors B, Serruys P, et al
    TCT-60 1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  34. WEBER J, Kassis N, Shah K, Lopez J, et al
    TCT-553 An Optical Coherence Tomography Comparison of Coronary Arterial Plaque Calcification in a Matched Cohort of Patients With and Without End-Stage Renal Disease and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  35. KENNEDY M, Hermanides R, Kaplan E, Hemradj V, et al
    TCT-512 Fractional Flow Reserve-Guided Deferred Versus Complete Revascularisation in Patients With Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  36. CHODVADIYA P, Testa L, Dani S, Desai DM, et al
    TCT-464 The Influence of Diabetes Mellitus on Clinical Outcomes Following Implantation of a novel abluminal coated sirolimus eluting stent that enhances drug delivery through the delivery balloon: Insights from en-ABL e-Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  37. KAUL U, Abhaichand DR, Patel T, Banker D, et al
    TCT-457 Paclitaxel - eluting stents vs Everolimus - eluting Coronary Stents in a Diabetic population: 2 Years Follow-up of TUXEDO-India Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  38. TOKLU B, Bangalore S, Kaul U, Attubato M, et al
    TCT-450 Bare Metal Stent, Durable Polymer Drug Eluting Stent, or Biodegradable Polymer Drug Eluting Stent in Patients with Diabetes Mellitus - A Mixed Treatment Comparison Analysis of 63,940 Patient-Years of Follow-up from Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  39. KRAAK R, Elias J, Kalkman D, Koch K, et al
    TCT-439 Increased incidence of revascularization in diabetic patients treated with the ABSORB everolimus-eluting bioresorbable scaffold: 24-months clinical results.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  40. CAMPOS C, Abizaid A, Caixeta A, Bartorelli A, et al
    TCT-411 Risk and timing of clinical events according to diabetic status of patients treated with Everolimus-Eluting Bioresorbable Vascular Scaffolds vs. Everolimus-Eluting stent: 2-Year results from a propensity score matched comparison of ABSORB EXTE
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  41. CHODVADIYA P, Dani S, Parikh K, Shetty R, et al
    TCT-390 Influence of Diabetes on the Safety and Efficacy of Sirolimus Coated Balloon in a Real-World Multi-Centre Nanolute Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  42. PANCHAL H, Zheng S, Abusara A, Mogusu E, et al
    TCT-272 National Trend in Hospitalization Cost for In-patient Single Vessel Percutaneous Coronary Intervention in Patients with and without Diabetes Mellitus in the United States: An Analysis from Nationwide Inpatient Sample from 2006-2011.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  43. CHOI KH, Choi JH, Yang JH, Choi SH, et al
    TCT-270 Long-term clinical outcomes of patients with coronary chronic total occlusion treated with percutaneous coronary intervention versus medical therapy according to presence of diabetes mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  44. VOGEL B, Baber U, Sartori S, Chandrasekhar J, et al
    TCT-271 Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  45. LEE SY, Garcia-Garcia HM, Kuku K, Azizi V, et al
    TCT-269 Impact of Incomplete Revascularization in Diabetes Mellitus Patients with Multivessel Disease Treated with Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  46. VOGEL B, Baber U, Chandrasekhar J, Aquino M, et al
    TCT-268 Impact of diabetes on outcomes after percutaneous coronary intervention in patients according to race/ethnicity.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  47. ROZEMEIJER R, Stein M, Voskuil M, Kraaijeveld A, et al
    TCT-267 Clinical outcomes of diabetic patients treated with an amphilimus-eluting stent and a short duration of dual antiplatelet therapy in routine clinical practice: first results of the Utrecht Cre8 (U-Cre8) Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  48. HERMANIDES R, Kedhi E, Kennedy M, van Dijk P, et al
    TCT-266 Impact of elevated glycosylated hemoglobin (HbA1c) on admission on long-term Mortality in Patients with Unknown Diabetes Mellitus Presenting with acute myocardial infarction (STEMI or NSTEMI).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  49. GODINO C, Pivato CA, Chiarito M, Donahue M, et al
    TCT-265 One-year Outcome of Polymer-free Amphilimus-eluting Stent versus Biodegradable Polymer Biolimus-eluting Stent in Diabetes Mellitus Patients. Propensity-Matched Analysis of the ASTUTE (AmphilimuS iTalian mUlticenTre rEgistry) and INSPIRE-1 (Ita
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  50. XU B, Murphy J, Yang Y, Qiao S, et al
    TCT-263 Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  51. PARADIES V, Vlachojannis G, Hofma SH, Togni M, et al
    TCT-264 Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes. 5 years follow-up from the COMPARE II trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  52. ELLERT J, Christiansen E, Maeng M, Raungaard B, et al
    TCT-261 Impact of Diabetes on Clinical Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer. From the SORT OUT VII Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  53. KENNEDY M, Kaplan E, Hermanides R, Fabris E, et al
    TCT-262 Clinical Outcomes of Deferred Revascularisation Using Fractional Flow Reserve in Patients With and Without Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  54. SALISBURY A, Sapontis J, Grantham JA, Qintar M, et al
    TCT-260 Outcomes of Chronic Total Occlusion PCI in Patients with Diabetes - Insights from the OPEN CTO Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  55. CHOUDHURY RP, Birks JS, Mani V, Biasiolli L, et al
    Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.
    J Am Coll Cardiol. 2016;68:1769-1780.
    PubMed     Text format     Abstract available


    September 2016
  56. VON HAEHLING S, Hasenfuss G, Anker SD
    Diabetes and Heart Failure: Sugared Words Prove Bitter.
    J Am Coll Cardiol. 2016;68:1417-9.
    PubMed     Text format    


  57. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure.
    J Am Coll Cardiol. 2016;68:1404-16.
    PubMed     Text format     Abstract available


  58. LEE AK, McEvoy JW, Hoogeveen RC, Ballantyne CM, et al
    Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study.
    J Am Coll Cardiol. 2016;68:1370-1.
    PubMed     Text format    


  59. POKHAREL Y, Gosch K, Nambi V, Chan PS, et al
    Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.
    J Am Coll Cardiol. 2016;68:1368-9.
    PubMed     Text format    


  60. MANCINI GB, Farkouh ME, Brooks MM, Chaitman BR, et al
    Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    J Am Coll Cardiol. 2016;68:985-95.
    PubMed     Text format     Abstract available


    August 2016
  61. HENRIQUES JP, Kikkert WJ
    Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm.
    J Am Coll Cardiol. 2016;68:739-41.
    PubMed     Text format    


  62. PICCOLO R, Eitel I, Galasso G, Dominguez-Rodriguez A, et al
    1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:727-38.
    PubMed     Text format     Abstract available


    July 2016
  63. BIETENBECK M, Yilmaz A
    An MR Spectroscopy-Based Approach to Lean Versus Obese Diabetic Patients.
    J Am Coll Cardiol. 2016;68:64-6.
    PubMed     Text format    


  64. LEVELT E, Pavlides M, Banerjee R, Mahmod M, et al
    Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes.
    J Am Coll Cardiol. 2016;68:53-63.
    PubMed     Text format     Abstract available


    May 2016
  65. ASLEH R, Levy NS, Doros G, Costacou T, et al
    Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With Diabetes.
    J Am Coll Cardiol. 2016;67:2553-4.
    PubMed     Text format    


  66. ASHBURNER JM, Singer DE
    Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2319.
    PubMed     Text format    


  67. OVERVAD TF, Bronnum Nielsen P, Bjerregaard Larsen T
    Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2318-9.
    PubMed     Text format    


    April 2016
  68. KNOWLES JW, Reaven G
    Usual Blood Pressure and New-Onset Diabetes Risk: Evidence From 4.1 Million Adults and a Meta-Analysis.
    J Am Coll Cardiol. 2016;67:1656-7.
    PubMed     Text format    


    February 2016
  69. MARIAN AJ
    Genetic Causality in Complex Traits: The Case of Uric Acid.
    J Am Coll Cardiol. 2016;67:417-9.
    PubMed     Text format    


  70. KEENAN T, Zhao W, Rasheed A, Ho WK, et al
    Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;67:407-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: